Actively Recruiting
Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones With Laser
Led by University Hospital, Tours · Updated on 2025-11-24
374
Participants Needed
9
Research Sites
117 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In view of the positive results of the numerous studies conducted on forced diuresis after extra-corporeal lithotripsy, the investigators chose to evaluate forced diuresis by injection of Furosemide associated with intravenous hydration, which has never before been the subject of a specific analysis.
CONDITIONS
Official Title
Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones With Laser
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years old and under 80 years old
- Need to undergo flexible ureteroscopy with laser destruction of kidney stones
- Covered by or entitled to social security
- Provided written informed consent
- Able to follow study requirements
You will not qualify if you...
- Pregnant women, breastfeeding mothers, minors, persons under legal protection, or deprived of liberty
- Allergy or sensitivity to Furosemide or sulfonamides
- Renal failure with oligo-anuria unresponsive to Furosemide
- Low potassium levels (hypokalemia < 3.5 mmol/L)
- Severe low sodium levels (hyponatremia)
- Low blood volume or dehydration, with or without low blood pressure
- Severe liver disease or ongoing hepatitis
- Currently taking Furosemide regularly
- Need for Aminoside or Vancomycin injection before or during procedure
- Participation in other interventional research involving drugs or medical devices
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 9 locations
1
CHU d'Angers
Angers, France
Actively Recruiting
2
Hospices Civils de Lyon
Lyon, France
Actively Recruiting
3
CHU de Nice
Nice, France
Actively Recruiting
4
CHU de Nîmes
Nîmes, France
Actively Recruiting
5
CHU de Rennes
Rennes, France
Actively Recruiting
6
CHU de Rouen
Rouen, France
Actively Recruiting
7
CHU de Toulouse
Toulouse, France
Actively Recruiting
8
Clinique La Croix du Sud
Toulouse, France
Actively Recruiting
9
CHRU de Tours
Tours, France
Actively Recruiting
Research Team
M
Marie-Lou LETOUCHE, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here